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Abstract Background Current trends in total joint replace-
ment have focused on shorter hospital stays. Purpose This study
aimed to determine if a pathway for total hip replacement (THR)
with the goal of a 2-day discharge (fast track) is safe and effective
compared to our traditional pathway (control). Methods One
hundred forty-nine patients undergoing unilateral, uncompli-
cated, THR were enrolled in an accelerated postoperative
pathway and 134 were enrolled in the traditional pathway.
Patients were followed prospectively and outcomes included
hospital length of stay, intra- and postoperative complications,
readmissions, reoperations. A statistical model was created to
determine factors predictive of a 2-day discharge. Results At
1 year, there were no differences in complications, readmissions,
or reoperations. The average length of stay decreased from 4.1 to
2.6 days (p<0.0001). In the fast track group, 58% of patients
were discharged home within 2 days. Barriers to a 2-day
discharge were postoperative pain, nausea, and dizziness. The
only preoperative factor that was predictive of a 2-day discharge
was hypertension. Conclusions In a select group of patients, a
protocol that allows for a 2-day discharge following THR is safe
and effective.
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Introduction
Current trends in total joint replacement, speciﬁcally total hip
replacement (THR), have focused on less-invasive surgical
approaches with the intent of providing quicker rehabilitation
and shorter hospital stays [2]. The extent to which these
innovative surgical approaches have inﬂuenced these goals
remains unclear. Regardless, public attention has focused on
these objectives and, increasingly, patients are requesting these
procedures with the goal of a shorter hospital stay in mind [19,
21]. Additionally, the economic realities of providing medical
care have motivated hospitals to reduce their average length of
stay for routine procedures [14].
In the USA, the average hospital length of stay
following THR has decreased from several weeks, to
between 3 and 6 days depending on the region of the
country and medical center involved [1, 21]. While this
decrease is in part due to the expanding role of rehabil-
itation centers in postoperative care, studies have found that
clinical pathways can also help reduce hospital stays and
improve the chances of patients being discharged home [2,
Each author certiﬁes that he or she has no commercial associations
(e.g., consultancies, stock ownership, equity interest, patent/licensing
arrangements, etc.) that might pose a conﬂict of interest in connection
with the submitted article.
Each author certiﬁes that his or her institution has approved the human
protocol for this investigation and that all investigations were
conducted in conformity with ethical principles of research. This
study was approved by the Institutional Review Board at the Hospital
for Special Surgery. Investigation performed at the Hospital for Special
Surgery.
Level of Evidence: Level II: Prospective Cohort Study
L. V. Gulotta, MD
Sports Medicine and Shoulder Service,
Hospital for Special Surgery, New York, NY, USA
D. E. Padgett, MD &T. P. Sculco, MD &B. J. Nestor, MD (*)
Arthroplasty Service,
Hospital for Special Surgery,
535 E 70th Street,
New York, NY 10021, USA
e-mail: nestorb@hss.edu
M. Urban, MD, PhD
Department of Anesthesiology,
Hospital for Special Surgery, New York, NY, USA
S. Lyman, PhD
Department of Epidemiology and Biostatistics,




Received: 5 January 2011/Accepted: 25 April 2011/Published online: 2 July 2011
11, 16, 18, 20]. These pathways are effective because they
align the goals of the patient and caregiver, and outline a
standardized plan to achieve these goals.
Clinical pathways have been become prevalent in joint
replacement surgery [6, 11, 13, 16–18, 20]. Kim et al.
performed a meta-analysis on 11 studies that evaluated the
effectiveness of clinical pathways for total knee and total
hip replacements [11]. They found that implementing a
clinical pathway signiﬁcantly reduced the average length of
stay. They also found that clinical pathways either reduced
the incidence of complications or, at least, did not increase
these events. While reduced hospital stays meet the short-
term goals of early rehabilitation and limiting hospital costs,
there is concern that discharging patients home too early
can result in unrecognized perioperative complications that
ultimately affect patient’s long-term outcome.
An existing clinical pathway for THR at our hospital
was modiﬁed with the goal of reducing hospital stays to
2 days in a safe and effective manner. We refer to this
pathway as the “Fast Track”. The purpose of this study was
threefold. First, we aimed to determine if patients enrolled
in the fast track pathway had a shorter length of stay when
compared to matched controls who experienced the stand-
ard postoperative pathway. Second, we aimed to report on
the safety and feasibility of this modiﬁed clinical pathway
with respect to perioperative complications and complaints.
And third, we aimed to determine what barriers exist to a 2-
day discharge, and to determine if any predictors for success
could be identiﬁed. The hypothesis for this prospective,
nonrandomized clinical study is that a select group of patients
undergoing THR can be discharged from the hospital 2 days
after surgery, without any increase in complications or adverse
effects on short-term clinical outcomes.
Methods
Between 2004 and 2006, 149 patients undergoing
unilateral, uncomplicated, THR by one of the three senior
arthroplasty surgeons were enrolled in this prospective
study to examine the safety and efﬁcacy of a 2-day length
of stay following THR. These patients made up the fast
track cohort. During the same time period, 134 patients
undergoing THR by another senior arthroplasty surgeon
were matched for age, sex, body mass index (BMI), and
comorbidities. This control group of patients followed our
hospital’s traditional clinical pathway following THR. The
traditional pathway was based on a discharge goal of 4 days.
The study was approved by the Institutional Review Board
at our hospital and all patients consented to participate.
Patients were selected for enrollment in the study based
on deﬁned inclusion criteria as follows: age between 18 and
70 years undergoing uncomplicated, unilateral, primary
total hip replacement surgery; American Society of Anes-
thesiologists (ASA) Class II or less with no signiﬁcant
comorbidities and no history of myocardial infarction,
pulmonary embolism, or deep venous thrombosis; BMI
less than 35; preoperative hemoglobin greater than 13.0 g/
dl; preoperative ambulation without a cane, or over 1,500 ft
with a cane; excellent social support as determined by a
social worker; and most importantly, patients needed to be
motivated to comply with the study protocol.
Exclusion criteria for the study included patients with
inﬂammatory arthritis, complex THR, and medical comorbid-
ities such as a history of a myocardial infarction, pulmonary
embolus, or deep venous thrombosis (DVT) such that they
were not candidates for multi-modal DVT prophylaxis with
aspirin and intermittent compression boots. Patients were also
excluded if they did not have someone at home that could stay
with them after they were discharged home, or if they had no
desire to participate in the pathway. The inclusion and
exclusion criteria are outlined in Table 1. This set of inclusion
and exclusion criteria applied to patients enrolled in either
cohort, fast track or control. All patients in both the fast track
group, and the control group were discharged home and not to
a rehabilitation facility.
A multidisciplinary team including representatives from
nursing, physical therapy, social services, anesthesiology,
hospital administration, and orthopedic surgery were
involved in development of the fast track protocol. The
goal was to develop a clinical pathway aimed at a 2-day
length of stay without compromising the standard of care at
our hospital. Appropriate daily patient goals were outlined
and postoperative orders were modiﬁed and standardized to
meet these goals. The new protocol, fast track, was devised
from a pre-existing clinical pathway with a number of
modiﬁcations (Table 2). Ambulation with physical therapy
began within 6 h of surgery in the fast track pathway rather
Table 1 Inclusion and exclusion criteria for participation in the fast track program
Inclusion criteria Exclusion criteria
Age 18–70 years old Inﬂammatory Arthritis
Unilateral, primary THR DDH with high hip center, or concomitant procedure such as removal of
hardware at time of THR
ASA class II or less History of myocardial infarction, pulmonary embolus, deep venous
thrombosis, diabetes mellitus
BMI<32
Preoperative hemoglobin >13 g/dl
Excellent social support Unable to arrange to have someone stay with patient after discharge
Preoperative ambulation without cane, or >1,500 ft with cane.
Motivated to comply with fast track protocol
THR total hip replacement, ASA American Society of Anesthesiologists, BMI body mass index, DDH developmental dysplasia of the hip
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than beginning the day after surgery as was the protocol in
the traditional pathway. Patients ambulated two additional
times on the day of surgery. To facilitate physical therapy on
the day of surgery, a fast track patient’s surgery was
scheduled for either the ﬁrst or second case of the day.
Subsequently, patients were seen by physical therapy twice
each day until the time of discharge. Acute postoperative
pain management was systemized such that each patient
received a dilaudid and marcaine epidural patient-controlled
analgesia (PCA) that was automatically discontinued on the
morning of postoperative day 1 if the patient’s pain visual
analog score (VAS) was 2 or less. In the traditional pathway,
the epidural PCA was routinely discontinued on post-
operative day 2. All patients received enteric-coated aspirin,
325 mg daily, and intermittent compression boots for DVT
prophylaxis and were discharged home with arrangements
for a physical therapist to work with the patient at home
upon discharge. Finally, a study coordinator conducted a
phone interview the day after discharge and 1 week after
discharge to ensure the patients were doing well and to
screen for complications.
Once the pathway was developed, additional patient
education material and a modiﬁcation to an existing
preoperative education class were created for patients and
their families to inform them about the fast track protocol.
Patients were counseled regarding pain control, physical
therapy regimens, nausea management, and techniques for
preventing atelectasis. Daily goals were outlined to the
patients and the strategies for attaining these goals were
discussed.
Data was extracted from the Collaborative Orthopedic
Replacement Registry including information regarding dem-
ographics, length of stay, intra-operative and postoperative
complications. Hospital charts were reviewed for readmis-
sions and reoperations, reasons for delayed discharge, daily
VAS, narcotic and anti-emetic usage, and the occurrences of
dizziness and nausea that either shortened or precluded a
patient’s participation in physical therapy. Patients were
followed for 1 year following their index surgery.
A chi-squared test was used to determine that had no
difference between groups based on sex. Likewise, an
independent samples t test was used to demonstrate no
signiﬁcant difference between groups based on age and
BMI. For testing of hypotheses, inferential statistics were
calculated using a Fisher’s exact test for risk of readmission
and reoperation between the fast track and standard cohorts.
An independent samples t test was used to calculate
differences between the groups with regard to length of
stay. A prediction model was built using multiple logistic
regression equation using only the fast track patients. Age,
sex, and BMI were forced into this model while all other
potential predictors were evaluated ﬁrst with univariate
analyses (Fisher’s or t tests as appropriate). Those deemed
to be associated (p<0.25) with failure to achieve early
discharge were eligible for inclusion. Those that achieved
statistical signiﬁcance (p<0.05) were retained in the model.
All analyses were performed using SPSS for Windows
version 13.0 (Chicago, IL).
Results
There were no signiﬁcant differences between the fast track
and control groups in terms of age, gender, BMI, primary
diagnosis, comorbidities, or femoral ﬁxation of the implant
(Tables 3 and 4).
Length of Stay
The average length of stay in the fast track group was 2.6±
0.9 days, which was signiﬁcantly shorter than for patients in
the control group (4.1±1.5 days; p<0.0001). Of the patients
participating in the fast track protocol, 58% were success-
fully discharged home within 2 days of surgery, and 73%
were discharged home within 3 days.
Table 2 Patient goals by postoperative day
Day of surgery Postoperative day 1 Postoperative day 2
First or second case of day Discontinue surgical drain and Foley catheter Surgical dressing removed
Ambulate with PT, progress to WBAT
with walker as tolerated
PT in morning, attempt to progress to crutches
or cane
PT in morning, progress to cane and work
on stairs/transfers
Epidural PCA for pain control Discontinue epidural PCA at 10 am If cleared by medical, surgical, and
PT teams →discharged home
Light liquids for lunch PT in the afternoon with similar goals, progress
to stairs if tolerated
Study coordinator calls home the day after
discharge to screen for care issues
Solid food for dinner
Begin ECASA for DVT prophylaxis
PT physical therapy, PCA patient-controlled analgesic, ECASA enteric-coated aspirin, DVT deep venous thrombosis, WBAT weight bear as
tolerated






Age in years 50.3±8.9 52.3±8.5 0.06
Female sex 34.2% 40.3% 0.29
Body mass index 26.9±5.9 27.2±5.8 0.65
Primary diagnosis of OA 85.9% 86.6% 0.87
Any comorbidities 49.0% 47.0% 0.74
Uncemented implant 91.3% 95.5% 0.15
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Readmissions, Complications, and Complaints
There were ﬁve readmissions in the fast track group
(3.4%). Two patients had a dislocation that required closed
reduction in the Emergency Department. One patient
required femoral revision for a periprosthetic femoral
fracture. Another patient underwent acetabular cup revision
for early aseptic loosening. One patient was called back to
the hospital for a blood transfusion the same day of
discharge for signiﬁcant anemia. That patient was subse-
quently discharged home later that evening following the
transfusion. All ﬁve of these patients were discharged home
within 2 days of surgery and were therefore classiﬁed as
successful 2-day discharge patients. There was only one
readmission in the control group (0.8%, p=0.22). This was
for a dislocation, which required open reduction and
revision of the prosthesis. There were no differences in the
rates of overall complications between the fast track and
control groups (Table 4).
There were two major postoperative medical complica-
tions in the fast track group. One patient experienced a
gastrointestinal bleed on postoperative day 1 requiring transfer
to the medical intensive care unit. Another patient had a
pulmonary embolus resulting in atrial ﬁbrillation, also on
postoperative day 1. Both patients recovered with medical
management and were discharged home within 6 days.
When postoperative complaints were assessed, there
was a lower rate of postoperative dizziness in the fast track
group (18.8%) compared to the control group (41.8%, p<
0.0001). There were higher rates of oral narcotic use in the
fast track group on POD#1 (68.5% vs. 32.1%, p<0.0001)
and on POD#2 (66.4% vs. 42.5%, p<0.0001) than in the
control group.
In 14% of all study patients, the patients were cleared
for discharge home within 2 days of surgery by the medical
team and physical therapy; however, arrangements for
discharge were not able to be made. A protocol violation
occurred for three patients that were originally in the fast
track cohort (2%) when they were not seen by physical
therapy within 6 h of surgery.
Predictors of a Successful 2-Day Discharge
When a predictive model was constructed to determine
the likelihood of success for a 2-day discharge for
patients enrolled in the fast track pathway, the only
preoperative predictor that could be determined was the
presence of hypertension. Patients with no history of
hypertension were 3.25 times more likely to be dis-
charged home within 2 days compared to those with
hypertension (95% CI, 1.39–7.60; p<0.006; Table 5).
Patients who experienced no postoperative nausea
were 3.41 times more likely to be discharged within
2 days than those who did (95% CI, 1.3–8.92; p=0.01).
Patients who did not experience dizziness were 16.1
times more likely to be successful than those who did not
(95% CI, 5.58–46.6; p<0.0001).
Discussion
There were no differences in the complication, readmis-
sion, and reoperation rates for the fast track group compared
to the control group in this study. We feel this proves that a
2-day discharge following uncomplicated THR in a select
group of relatively healthy patients is safe. Patients enrolled
in the fast track protocol had an average length of stay of
2.6 days, which was signiﬁcantly shorter than an average
length of stay of 4.1 days for the matched control group.
Table 4 Fast track cohort compared to matched controls who






Length of stay in days 2.6±0.9 4.1±1.5 <0.0001
Common post-op complaints/complications
Reoperation 2 (1.3%) 1 (0.8%) 0.99
Readmission 5 (3.4%) 1 (0.8%) 0.22
Local complications 7 (4.7%) 7 (5.2%) 0.84
Dislocation 3 (2.0%) 2 (1.5%) 0.99
Drainage 1 (0.7%) 2 (1.5%) 0.61
Gout None 2 (1.5%) 0.22
Respiratory dysfunction 1 (0.7%) None 0.99
Pulmonary embolus 1 (0.7%) None 0.99
Atrial ﬁbrillation 1 (0.7%) 1 (0.8%) 0.99
Urinary tract infection 1 (0.7%) 1 (0.8%) 0.99
Dizziness 28 (18.8%) 56 (41.8%) <0.0001
Nausea 20 (13.4%) 29 (21.6%) 0.07
Postoperative pain (VAS):
Day 0 3.0±1.9 2.7±1.3 0.19
Day 1 2.2±1.3 2.2±1.1 0.90
Day 2 1.8±1.3 1.8±0.8 0.72
Narcotic use:
Day 0 10.1% 3.0% 0.01
Day 1 68.5% 32.1% <0.0001
Day 2 66.4% 42.5% <0.0001
Anti-emetic use:
Day 0 58.1% 49.3% 0.17
Day 1 13.4% 18.7% 0.24
Day 2 4.8% 9.0% 0.19
Table 5 Predictive model for successful discharge at 2 days for
patients participating in the fast track pathway
Variable Odds ratio 95% CI p value
Age 0.99 0.96, 1.03 0.71
Male sex 1.81 0.93, 3.52 0.08
BMI 1.06 0.99, 1.13 0.06
No hypertension 3.25 1.39, 7.60 0.006
No nausea 3.41 1.30, 8.92 0.01
No dizziness 16.1 5.58, 46.6 <0.0001
Narcotics on
day 1
3.43 1.05, 11.2 0.04
Narcotics on
day 2
1.80 1.00, 3.24 0.05
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This suggests that the program is effective in reducing
length of stay. The most common barriers to a successful 2-
day discharge were postoperative nausea and dizziness that
interfered with physical therapy.
While the overall readmission rate was not statistically
different between the fast track and control groups, all ﬁve
patients that were readmitted in the fast track group were
successfully discharged from the hospital within 2 days of
their surgery. No fast track patients that were discharged
after 2 days were readmitted. One patient was readmitted
for a blood transfusion that may have been prevented had
the patient not been discharged within 2 days. However, our
protocol had an infrastructure in place to follow-up and
identify patients that require further medical care following
discharge and the transfusion was addressed in a timely
manner. Of the other four patients who were readmitted,
there were two dislocations and one periprosthetic fracture.
The relationship that these complications have with a
shortened hospital stay is uncertain. Previous authors have
suggested that a shortened hospital stay is associated with a
higher dislocation rate; however, this did not reach
signiﬁcance in the present study [13].
Several factors are involved in developing a successful
clinical pathway following total joint procedures. Probably
the most important factor in our study was patient selection
criteria. Jain et al. found that hypertension, diabetes, and
obesity were each independent risk factors for postoperative
complications [10]. Forrest et al. found that only patient age
was correlated to length of stay, but age and diabetes were
predictive of discharge to a rehabilitation center [8]. Bozic
et al. also found older age and higher ASA Class were
predictive of a discharge to a rehabilitation facility [5].
Hayes et al. found that patient’s age, female gender, and
number of comorbidities inﬂuenced length of stay [9].
The ﬁndings in our study are similar to those previously
reported. While patients with comorbidities such as dia-
betes, previous myocardial infarction, and morbid obesity,
and patients with an ASA of Class II or higher were
excluded from participation, we did ﬁnd that patients with
hypertension were over three times less likely to be
discharged home within 2 days when enrolled in the fast
track protocol. We currently do not include hypertension as
a contraindication for participation in the fast track protocol.
While many studies have shown that clinical pathway
can safely reduce stays to within 3–5 days of surgery, very
few have looked at earlier discharges. Berger et al. showed
that 97 of 100 patients who underwent two-incision
minimally invasive THR were discharged home on the
day of surgery [4]. They reported no dislocations, reopera-
tions, or readmissions to the hospital. More recently in a
follow-up to that study, the same group reported 9% rate of
either readmission or emergency room visits following
discharge [3]. However, in those studies, it is unclear if all
patients were discharged home as was the case in the
current study. In our study, there were two major medical
complications in the fast track group in addition to the
previously mentioned ﬁve readmissions. One patient had a
gastrointestinal bleeding and another had a pulmonary
embolism resulting in atrial ﬁbrillation. Both complications
occurred on postoperative day 1 and were managed with
little subsequent morbidity.
Perioperative anesthesia and its complications are other
factors that inﬂuence length of stay. Postoperative pain,
nausea, and dizziness that interfered with physical therapy
were the main reasons for an unsuccessful 2-day discharge.
In our study, all patients were placed on an epidural PCA.
Continuous epidurals can control pain in the immediate
postoperative period, and can allow earlier attainment of
functional goals when compared to general anesthesia [2].
The PCA was routinely discontinued after 24 h and the
patients were switched to oral pain medication by the end of
postoperative day 1 in the fast track group. It is possible that
patients with an unsuccessful 2-day discharge were more
sensitive to the medications in the epidural, thus resulting in
increased rates of nausea and dizziness and prolonged stays.
Also, beginning ambulation with physical therapy within
6 h of surgery may contribute to nausea and dizziness as
well. These ﬁndings raise the question as to whether more
aggressive, preemptive anti-emetic usage is warranted in
patients eligible for fast track discharge. Future research
will explore the use of a low opioid pathway to eliminate
these complications.
Another factor in a successful clinical pathway is
preoperative education. McGregor et al. found that preop-
erative classes and booklets reduced hospital stays by
3 days, and resulted in higher patient satisfaction due to
more realistic expectations of surgery [15]. Daltroy et al.
also showed that patients undergoing preoperative educa-
tion, including psychosocial preparation, had reduced
hospital stays and required less pain medication post-
operatively [7]. The fast track pathway presented in this
study includes a mandatory preoperative education class
that is taught by a multidisciplinary team [12].
We acknowledge several limitations in our study. The
patients were not randomized and that may have contributed
to a patient selection bias. Second, actual cost savings were
not calculated for this study. It is possible that the added
costs of physical therapy, nursing, and social work needed
to institute the fast track pathway did not outweigh the
savings that early discharges afforded. Third, this study was
conducted at a large orthopedic specialty hospital that
performs over approximately 2,500 THR’s annually. This
represents a small subset of that experience and the results
may not be generalizable to hospitals with smaller volume
and a less specialized staff. And ﬁnally, there is the
possibility that signiﬁcant differences in complications and
readmissions were not found in this study due to its sample
size limitations.
Our ﬁndings support our hypothesis that a 2-day length
of stay protocol following THR can be safe and effective.
The pathway reduced the overall length of stay in our
hospital regardless of whether patients successfully met the
2-day discharge goal or not. The complications following
surgery were comparable to those previously reported for
patients undergoing THR. Further research is needed to
determine ways to reduce the incidence of postoperative
nausea and dizziness, since these were the most important
factors that delayed discharge.
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